← Eichor
Study identifier: NCT07220538 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment

Condition: Ischemic Stroke Hospitalized · Impairment, Cognitive  ·  Sponsor: Dr. Willmar Schwabe GmbH & Co. KG

PhasePhase 4
Planned participants400
Who can joinAll sexes, 55 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if Extract of Ginkgo Biloba Leaves Tablets help improve thinking and memory in people aged 55 years and older who had an ischemic stroke (a type of stroke caused by a blocked blood vessel in the brain). It will also look at how safe the Extract of Ginkgo Biloba Leaves Tablets are. The main questions it aims to answer are: * Do the Extract of Ginkgo Biloba Leaves Tablets help people with memory or thinking problems after an ischemic stroke? * What medical problems do people have when taking the Extract of Ginkgo Biloba Leaves Tablets ? Researchers will compare people who take the Extract of Ginkgo Biloba Leaves Tablets along with their usual post-stroke treatment to people who only receive their usual post-stroke treatment. Participants will: * Have had an ischemic stroke confirmed by MRI (Magnet Resonance Imaging, a magnetic scan that helps seeing inside the body in great detail) 7 to 14 days before joining the study * Take Extract of Ginkgo Biloba Leaves Tablets (240 mg per day) in addition to usual post-stroke treatment for 12 months, or receive only usual post-stroke treatment for 12 months * Be treated initially at hospitals across China * Visit the clinic 4, 26, and 52 weeks following the baseline for checkups and tests, and receive follow-up calls after 12 and 38 weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Project Manager  ·  +497214009583  ·  sandra.christochowitz@schwabe.de

Senior Medical Advisor, M.D., Ph.D  ·  +4972140059750  ·  marilia.soria@schwabe.de

Always discuss trial participation with your own doctor first.

Locations (40)

The People's Hospital of Anyang CityAnyang, ChinaRecruiting
Baotou Central HospitalBaotou, ChinaRecruiting
Tiantan HospitalBeijing, ChinaRecruiting
Beipiao Central HospitalBeipiao, ChinaRecruiting
Benxi Central HospitalBenxi, ChinaRecruiting
The First People's Hospital of ChenzhouChenzhou, ChinaRecruiting
Affiliated Hospital of Chifeng UniversityChifeng, ChinaActive Not Recruiting
Affiliated Zhongshan Hospital of Dalian UniversityDalian, ChinaRecruiting
Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)Dalian, ChinaRecruiting
Dalian Lvshunkou District Traditional Chinese Medicine HospitalDalian, ChinaRecruiting
Dalian University Affiliated Xinhua HospitalDalian, ChinaRecruiting
Hainan General HospitalHainan, ChinaRecruiting

+ 28 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07220538